![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Switzerland is practically unknown in the drug/medical device regulatory landscape despite being home to some of the world's biggest pharmaceutical firms. This article briefly describes the regulations governing clinical trials in Switzerland and cites examples of Swiss-specific regulatory documents.
Additional information
Notes on contributors
Raquel Billiones
Raquel Billiones earned her BSc in Biology at the University of the Philippines and did her postgraduate studies (MSc and PhD) at the Free University of Brussels in Belgium. After completing her postdoctoral fellowship at the J.W. Goethe University Frankfurt in Germany, she switched to medical writing and never looked back. She is currently working as a senior medical writer for the dCRO (d as in digital) Clinipace Worldwide at their EU headquarters in Zurich, Switzerland. Raquel has lived, studied and worked in five different countries in Asia and Europe.